Does NATALIZUMAB Cause Central nervous system lesion? 627 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 627 reports of Central nervous system lesion have been filed in association with NATALIZUMAB (TYRUKO). This represents 1.0% of all adverse event reports for NATALIZUMAB.
627
Reports of Central nervous system lesion with NATALIZUMAB
1.0%
of all NATALIZUMAB reports
13
Deaths
211
Hospitalizations
How Dangerous Is Central nervous system lesion From NATALIZUMAB?
Of the 627 reports, 13 (2.1%) resulted in death, 211 (33.7%) required hospitalization, and 6 (1.0%) were considered life-threatening.
Is Central nervous system lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 627 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Central nervous system lesion?
FINGOLIMOD (2,416)
DIMETHYL (1,152)
INTERFERON BETA-1A (978)
DALFAMPRIDINE (561)
GLATIRAMER (492)
TERIFLUNOMIDE (315)
ADALIMUMAB (229)
OFATUMUMAB (185)
RITUXIMAB (151)
METHOTREXATE (147)
Which NATALIZUMAB Alternatives Have Lower Central nervous system lesion Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK